Valuation: Shivalik Rasayan Limited

Market Cap 3.49B 36.64M 31.85M 29.73M 27.29M 51.47M 52.36M 351M 137M 1.74B 138M 135M 5.74B P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 4.26B 44.7M 38.84M 36.27M 33.29M 62.78M 63.87M 428M 167M 2.12B 168M 164M 7.01B EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
41.43%
Yield 2024
0.09%
Yield 2025 0.08%
Jul. 23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
May. 27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
May. 27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
May. 27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
May. 27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
Feb. 13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Nov. 14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
25-08-12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-05-29 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
25-04-23 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
25-02-25 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD CI
1 day+4.45%
1 week+1.20%
Current month+4.45%
1 month+9.25%
3 months-1.26%
6 months-15.13%
Current year-27.50%
1 week 246.1
Extreme 246.1
271.4
1 month 211.45
Extreme 211.45
271.4
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
634
3 years 206
Extreme 206
890.05
5 years 206
Extreme 206
1,196.8
10 years 53.24
Extreme 53.24
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 2018-11-16
Director of Finance/CFO - 2001-10-31
Chief Tech/Sci/R&D Officer - 2024-01-10
Director TitleAgeSince
Chairman 62 2002-02-22
Director/Board Member 67 2003-07-17
Director/Board Member - 2018-11-12
Date Insider Type Main position Quantity % Market Cap.
7/1/24 Don 21,500 0.1382%
6/26/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+4.45%+1.20%-56.32%-68.31% 40.75M
-2.74%-12.21%+6.91%+38.07% 52.51B
+0.11%-.--%-.--%-.--% 12.96B
+1.68%-1.63%+29.75%+169.06% 10.48B
-1.07%+2.60%+22.01%+61.74% 8.06B
+0.69%-1.07%-15.37%-16.75% 6.53B
+2.01%+4.19%-9.66%+76.12% 5.6B
+3.41%+3.80%-5.98%+0.95% 5.34B
+2.30%+10.83%+35.67%+46.05% 5.11B
+2.90%+3.62%-32.39%-23.18% 4.37B
Average +1.37%-0.09%-2.54%+28.37% 11.1B
Weighted average by Cap. -0.70%-4.66%+6.34%+42.53%

Financials

2024 2025
Net sales 2.72B 28.49M 24.76M 23.12M 21.22M 40.01M 40.71M 273M 107M 1.35B 107M 105M 4.47B 3.1B 32.48M 28.23M 26.35M 24.19M 45.61M 46.41M 311M 122M 1.54B 122M 119M 5.09B
Net income 127M 1.33M 1.16M 1.08M 994K 1.87M 1.91M 12.77M 5M 63.42M 5.01M 4.9M 209M 167M 1.75M 1.52M 1.42M 1.3M 2.46M 2.5M 16.76M 6.56M 83.26M 6.58M 6.43M 275M
Net Debt 482M 5.06M 4.4M 4.11M 3.77M 7.11M 7.23M 48.41M 18.96M 241M 19.01M 18.59M 793M 768M 8.05M 7M 6.53M 6M 11.31M 11.51M 77.05M 30.18M 383M 30.25M 29.58M 1.26B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
26-08-03 258.00 +4.45% 3,331
26-07-31 ₹247.00 -5.00% 2,116
26-07-30 ₹260.00 +1.76% 1,002
26-07-29 ₹255.50 -1.73% 1,500
26-07-28 ₹260.00 -0.73% 3,500
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock